Design Therapeutics, Inc.DSGNNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Loading chart...

Alerts

Want to monitor DSGN?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor DSGN

Key Statistics

About

Design Therapeutics is a biotechnology company developing a new class of therapies based on a platform of gene targeted chimera (GeneTAC™) small molecules. The company’s lead program is focused on the treatment of Friedreich ataxia, followed by a program in myotonic dystrophy type-1 and discovery efforts for multiple other serious degenerative disorders caused by nucleotide repeat expansions.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology

www.designtx.com →